View in EDS

NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated.

Saved in:
Bibliographic Details
Title: NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated.
Authors: Freeman TJ; NSABP Foundation, Inc, Pittsburgh, PA, USA. Tanner.Freeman@NSABP.org.; University of Pittsburgh, Pittsburgh, PA, USA. Tanner.Freeman@NSABP.org., George TJ; NSABP Foundation, Inc, Pittsburgh, PA, USA.; The University of Florida Health Cancer Center, Gainesville, FL, USA., Jacobs SA; NSABP Foundation, Inc, Pittsburgh, PA, USA., Yothers G; University of Pittsburgh, Pittsburgh, PA, USA.; NSABP/NRG Oncology, Pittsburgh, PA, USA., Kolevska T; Kaiser Permanente Northern California, Vallejo, CA, USA., Feng H; NSABP Foundation, Inc, Pittsburgh, PA, USA., Lipchik C; NSABP Foundation, Inc, Pittsburgh, PA, USA., Maley S; NSABP Foundation, Inc, Pittsburgh, PA, USA., Song N; NSABP Foundation, Inc, Pittsburgh, PA, USA., Srinivasan A; NSABP Foundation, Inc, Pittsburgh, PA, USA.; Lipedema Foundation, Autism Impact Fund, New York, NY, USA., Finnigan M; NSABP Foundation, Inc, Pittsburgh, PA, USA., Wade JL 3rd; Cancer Care Specialists of Illinois/Heartland and NCORP, Decatur Memorial Hospital, Decatur, IL, USA., Buchschacher GL Jr; Kaiser Permanente Southern California, Los Angeles, CA, USA., Al Baghdadi T; Trinity Health IHA Ann Arbor Hospital, Michigan Cancer Research Consortium (NCORP), Ypsilanti, MI, USA., Shipstone A; Ballad Health Cancer Care, Kingsport, TN, USA., Lin D; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Puhalla SL; University of Pittsburgh, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Allegra CJ; NSABP Foundation, Inc, Pittsburgh, PA, USA.; The University of Florida Health Cancer Center, Gainesville, FL, USA., Wolmark N; NSABP Foundation, Inc, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Pogue-Geile KL; NSABP Foundation, Inc, Pittsburgh, PA, USA.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2025 Aug 09; Vol. 95 (1), pp. 80. Date of Electronic Publication: 2025 Aug 09.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40782152
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Freeman+TJ%22">Freeman TJ</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA. Tanner.Freeman@NSABP.org.; University of Pittsburgh, Pittsburgh, PA, USA. Tanner.Freeman@NSABP.org.<br /><searchLink fieldCode="AU" term="%22George+TJ%22">George TJ</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.; The University of Florida Health Cancer Center, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Jacobs+SA%22">Jacobs SA</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Yothers+G%22">Yothers G</searchLink>; University of Pittsburgh, Pittsburgh, PA, USA.; NSABP/NRG Oncology, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kolevska+T%22">Kolevska T</searchLink>; Kaiser Permanente Northern California, Vallejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Feng+H%22">Feng H</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lipchik+C%22">Lipchik C</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Maley+S%22">Maley S</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Song+N%22">Song N</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Srinivasan+A%22">Srinivasan A</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.; Lipedema Foundation, Autism Impact Fund, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Finnigan+M%22">Finnigan M</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wade+JL+3rd%22">Wade JL 3rd</searchLink>; Cancer Care Specialists of Illinois/Heartland and NCORP, Decatur Memorial Hospital, Decatur, IL, USA.<br /><searchLink fieldCode="AU" term="%22Buchschacher+GL+Jr%22">Buchschacher GL Jr</searchLink>; Kaiser Permanente Southern California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Al+Baghdadi+T%22">Al Baghdadi T</searchLink>; Trinity Health IHA Ann Arbor Hospital, Michigan Cancer Research Consortium (NCORP), Ypsilanti, MI, USA.<br /><searchLink fieldCode="AU" term="%22Shipstone+A%22">Shipstone A</searchLink>; Ballad Health Cancer Care, Kingsport, TN, USA.<br /><searchLink fieldCode="AU" term="%22Lin+D%22">Lin D</searchLink>; Thomas Jefferson University Hospital, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Puhalla+SL%22">Puhalla SL</searchLink>; University of Pittsburgh, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Allegra+CJ%22">Allegra CJ</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.; The University of Florida Health Cancer Center, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Wolmark+N%22">Wolmark N</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Pogue-Geile+KL%22">Pogue-Geile KL</searchLink>; NSABP Foundation, Inc, Pittsburgh, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2025 Aug 09; Vol. 95 (1), pp. 80. <i>Date of Electronic Publication: </i>2025 Aug 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40782152
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-025-04802-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 80
    Titles:
      – TitleFull: NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Freeman TJ
      – PersonEntity:
          Name:
            NameFull: George TJ
      – PersonEntity:
          Name:
            NameFull: Jacobs SA
      – PersonEntity:
          Name:
            NameFull: Yothers G
      – PersonEntity:
          Name:
            NameFull: Kolevska T
      – PersonEntity:
          Name:
            NameFull: Feng H
      – PersonEntity:
          Name:
            NameFull: Lipchik C
      – PersonEntity:
          Name:
            NameFull: Maley S
      – PersonEntity:
          Name:
            NameFull: Song N
      – PersonEntity:
          Name:
            NameFull: Srinivasan A
      – PersonEntity:
          Name:
            NameFull: Finnigan M
      – PersonEntity:
          Name:
            NameFull: Wade JL 3rd
      – PersonEntity:
          Name:
            NameFull: Buchschacher GL Jr
      – PersonEntity:
          Name:
            NameFull: Al Baghdadi T
      – PersonEntity:
          Name:
            NameFull: Shipstone A
      – PersonEntity:
          Name:
            NameFull: Lin D
      – PersonEntity:
          Name:
            NameFull: Puhalla SL
      – PersonEntity:
          Name:
            NameFull: Allegra CJ
      – PersonEntity:
          Name:
            NameFull: Wolmark N
      – PersonEntity:
          Name:
            NameFull: Pogue-Geile KL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 08
              Text: 2025 Aug 09
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 95
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1